Abstract
Introduction:
Transfusion of blood is a lifesaving intervention and millions of units of blood are collected and transfused every year worldwide [1] [2] [3] [4] [5] . It is a specialized modality of patient management; primary purpose is to increase oxygen supply by increasing arterial content of oxygen, which is dependent on the hemoglobin level [6] [7] [8] [9] [10] . The decision to transfuse a hospitalized patient must balance the known risks of transfusion with appropriate utilization of blood as a scarce resource 11 . Although multiple critical steps are taken to minimize the risk of infection from transfusion of blood or blood products in developed countries, the risk of transmission of disease through transfusion, can never be entirely eliminated 6, 12 . Thus it should be considered in terms of risk versus benefit 6 . Transfusions should be planned judiciously and, side by side, efforts should be made to minimize the risk of disease transmission through adopting the guidelines of World Health Organization (WHO) for safe blood transfusion 6 .
The decision to transfuse should be individualized, based on a rational approach and taking into account the hemoglobin value in addition to physiologic variables 10 . In any decision to transfuse, one must weigh the risks and benefits associated with transfusion against those associated with anemia. Although blood transfusions have been associated with adverse outcomes, anemia is also associated with increased mortality rates [13] [14] [15] [16] . The costs of blood transfusion are particularly complex to assess because of the many factors that have to be taken into consideration such as blood collection and screening for pathogens; blood component processing, including leuko reduction, storage, transport to the transfusion facility; administration of blood to the patient; management of potential short-and long-term transfusion-related side effects 10, 17 .
A common assumption among clinicians is that the transfusion of a ''unit'' of blood will result in a 3% increase in the hematocrit or 1 g/dL of hemoglobin [18] [19] [20] [21] . It has been implied that blood volume is expanded immediately after transfusion and does not return to normal for 24 hours 22 . Wiesen et al (1994) 23 24 .
The purpose of this study was to determine more precisely how much of an increase in the haemoglobin is produced by transfusion of a fresh whole blood in a clinical setting. It also conducted to describe the time required for equilibration of hemoglobin concentration after single unit fresh whole blood transfusion in medical inpatients not actively bleeding. Study will enrich our knowledge and which will help to develop specific guideline of blood transfusion among the Bangladeshi population. This study will help to assist physicians and other healthcare providers in the correct selection of patients for transfusion and related laboratory test for safe administration of blood and blood products.
Methodology:
The present cross sectional study was conducted at the Department of Transfusion Medicine, Dhaka Medical College, Dhaka during the periods of July 2012 to June 2013. The protocol approved by Ethical Committee of Bangladesh Medical Research Council (BMRC) before commencement of the study. It was assured that all information and records would be kept confidential. Total 100 purposively selected admitted patients in the department of medicine of Dhaka Medical College Hospital (DMCH) undergone blood transfusion were the study population. The aims and objectives of the study along with its procedure, risks and benefits of this study were explained to the respondent in easily understandable local language. Patients age more than 18 years, normal kidney function, normal liver function, no active bleeding, and in a stable clinical phase of their disease and ability to give a written informed consent were included in the study. A structured questionnaire and a check list used as a research instrument after duly 30 in their study reported that 60.5% of donors were young, below 30 years of age and were predominantly male (91.6%).
A common assumption among clinicians is that the transfusion of one unit of blood will result in a 3% increase in the hematocrit or 1 g/dL of hemoglobin [18] [19] [20] [21] . It has been implied that blood volume is expanded immediately after transfusion and does not return to normal for 24 hours 22 . Mean±SD of Hb level before, at 6 hours and 24 hours after transfusion were 7.64±1.05, 8.03±1.07 and 8.78±1.19 gm/dl respectively. In the present study the mean increase of Hb 6 hours and 24 hours after transfusion were 0.39 gm/dl and 1.14 gm/dl respectively. Huber et al. (1964) 18 found the average increase in hemoglobin concentrations was 0.9 ±0.1 g/dL) in a study of 16 adult patients with mild splenomegaly. Wiesen et al (1994) 23 in their study concluded that transfusion with 1 unit of packed erythrocytes increases the hemoglobin level an average of 10 g/L (1.0 g/dL). Mungayi et al. (2014) 31 in their study reported that the mean 24 in their study reported that the agreement between 15-minute and 24-hour values was excellent, as only 6 percent of patients exhibited a clinically significant difference (> 6 g/L) between the hemoglobin measurements. This fact would allow a rapid assessment of the effects of transfusion and of the recurrence of bleeding in patients remaining at risk.
Conclusion:
The study revealed slightly more one gram increase of Hb at 24 hours after transfusion of one unit of whole blood among patients not actively bleeding. There is significant difference between Hb level at 6 hours and 24 hours after transfusion. A single centre study involving a small number of patients and luck of a homogenous study population are the limitations of this study. Collaborative research with multiple centers or institutions may be taken which will raise the scientific expertise of our researchers and physicians.
